Specifically, in a colorectal cancer (CRC) model, the primary cancer releases ITGBL1-enriched EVs to activate fibroblasts in distant organs, promote the secretion of the pro-inflammatory cytokines to induce the constitution of pre-metastatic niche or facilitate the progression of metastatic neoplasms [36]. Here, ITGBL1 is linked to cancer.